The first shipment of Lenacapavir arrived in South Africa from the United States in early April 2026.
The first shipment of Lenacapavir arrived in South Africa from the United States in early April 2026.
africaother
Lenacapavir is a long‑acting injectable that prevents HIV with two shots a year.
africaother
The first shipment of Lenacapavir, a long-acting injectable that prevents HIV with two shots a year, arrived in South Africa from the United States in early April 2026.
The first shipment of Lenacapavir, a long-acting injectable that prevents HIV with two shots a year, arrived in South Africa from the United States in early April 2026.
africaother
Lenacapavir is a long-acting injectable that prevents HIV with two shots a year.
africaother
The first shipment of Lenacapavir, a long-acting injectable that prevents HIV with two shots a year, arrived in South Africa from the United States in early April 2026.
The first shipment of Lenacapavir, a long-acting injectable that prevents HIV with two shots a year, arrived in South Africa from the United States in early April 2026.
africaother
Clinical trials showed close to 100% efficacy for Lenacapavir.
africaother
The first shipment of Lenacapavir, a long-acting injectable that prevents HIV with two shots a year, arrived in South Africa from the United States in early April 2026.
The first shipment of Lenacapavir, a long-acting injectable that prevents HIV with two shots a year, arrived in South Africa from the United States in early April 2026.
africaother
The rollout of Lenacapavir is expected to begin in June 2026.
africaother
The first shipment of Lenacapavir, a long-acting injectable that prevents HIV with two shots a year, arrived in South Africa from the United States in early April 2026.